Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. It also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.


TSX:ACB - Post by User

Bullboard Posts
Comment by MartialArtson May 17, 2018 7:49pm
75 Views
Post# 28049667

RE:RE:Pharmacies, generics, brands and strains

RE:RE:Pharmacies, generics, brands and strains
"Branding" has an uphill battle. There's a huge gap between what companies want to do and what government will allow.  I still maintain that strain and price will be the two top deciding factors for consumer. 

Ask anyone who is a customer of dispensaries.  I hang around and ask questions "for market research purposes".  People love to chat when you approach them with a smile and welcoming manner. "Excuse me, I'm doing market research, do you have a minute for a few questions".  In rougher neighbourhoods everyone takes a free $5 but in most cases, it doesn't cost me a dime.  It's strains and price.  People get very, very attached to some strains and will go to extremes to advocate for them.

Here's a relevant article on branding restrictions:

https://www.bloomberg.com/news/articles/2018-03-19/canada-details-packaging-rules-ahead-of-marijuana-legalization

"“Consistent with the Task Force on Cannabis Legalization and Regulation’s recommendation to require plain packaging of cannabis products, the regulations would set strict requirements related to the use of branding, logos, and colors,” Health Canada said in the report from Ottawa."

I would agree branding would be more significant if it wasn't for the strict Government oversight.
Bullboard Posts